Leading Edge Resources: Leaps in Technology and Access to Information
Cyberkinetics Neurotechnology Systems, Inc. is a neurotechnology innovator focused on the commercialization of two proprietary platforms for direct neural sensing in the brain, real-time neural signal decoding technology, and neural stimulation. The Company's mission is to commercialize products based upon these powerful platform technologies that restore function, including limb movement, sensation and communication, for those with a wide range of central nervous system conditions, diseases and injuries, such as spinal cord injury, ALS and other motor neuron diseases.
Cyberkinetcs Neurotechnology Systems, Inc. has pioneered The BrainGate™ Neural Interface System. The BrainGate™ Neural Interface System is currently the subject of a pilot clinical trial being conducted under an Investigational Device Exemption (IDE) from the FDA. The system is designed to restore functionality for a limited group of people with severe mobility disabilities. It is expected that people using the BrainGate™ System will employ a personal computer as the gateway to a range of self-directed activities. These activities may extend beyond typical computer functions (e.g., communication) to include the control of objects in the environment such as a telephone, a television and lights. http://www.cyberkineticsinc.com